“The development of the novel drug, TE-8105, the glucagon-like peptide-1 receptor agonist” was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan. The CDE case number is 110IDX04007.
Reported link: https://www.cw.com.tw/article/5100174
Reported link: https://www.immunwork.com/include/download.php?dl=MjAyMTAwNDI0X158ZmlsZXNhcHBlbmRzXnwwMDAwMDAwMDA0
Immunwork won the 2019 Outstanding Biotechnology Industry Award – Potential Benchmark Award. The News link:https://www.chinatimes.com/newspapers/20190718000247-260202?chdtv
Reported link: https://scitechvista.nat.gov.tw/Article/C000003/detail?ID=75032646-f582-4c67-a711-1bb1f66da968
